NIH NCATS seeks to be 'synergistic hub' for translational medicine
This article was originally published in Scrip
After two months of many in the US research community having kittens over a proposal to dismantle the US National Institutes of Health's centre that funds and provides resources for early research to make way for a new translational sciences centre by 1 October 2011, most internal and external scientists are now coming around to supporting the idea, NIH Director Dr Francis Collins told reporters 23 February.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.